摘要
目的 子宫腺肌病痛经采用针刺治疗的临床应用。方法 选取2023年7月—2024年10月武汉岐黄九针中医门诊80例患者随机分组,分别以药物治疗、针刺治疗干预,分析治疗效果、症候积分、康复情况。结果 研究组疗效显著97.50%,χ2=6.1346,P=0.0132。研究组经期小腹痛(1.05±0.32分)、行经不规律(1.16±0.48分)、经量异常(1.22±0.34分)低于对照组,P<0.05。研究组VAS(1.35±0.61分)低于对照组,P<0.05。研究组PBAC(45.86±5.56分)低于对照组,P<0.05。研究组严重程度(25.86±5.44分)、持续时间(22.45±2.86分)低于对照组,P<0.05。研究组子宫体积(90.45±5.19cm3)低于对照组,P<0.05。结论 针刺治疗子宫腺肌病痛经效果显著,能改善临床症状,缓解疼痛情况,值得推广。
关键词: 针刺;子宫腺肌病痛经;症候积分;疼痛水平
Abstract
Objective To explore the application of acupuncture in the treatment of dysmenorrhea caused by adenomyosis. Methods From July 2023 to October 2024, 80 patients from the Qihuang Jiuzhen Traditional Chinese Medicine Clinic in Wuhan were randomly divided into groups and treated with either medication or acupuncture. The therapeutic effects, symptom scores, recovery conditions, and serum sex hormones were analyzed. Results The effective rate of the study group was 97.50%, with χ2 = 6.1346, P = 0.0132. The study group had lower scores for dysmenorrhea during menstruation (1.05 ± 0.32), irregular menstruation (1.16 ± 0.48), and abnormal menstrual volume (1.22 ± 0.34) compared to the control group, with P < 0.05. The study group had a lower VAS score (1.35 ± 0.61) than the control group, with P < 0.05. The study group had a lower PBAC score (45.86 ± 5.56) than the control group, with P < 0.05. The study group had lower severity (25.86 ± 5.44) and duration (22.45 ± 2.86) scores than the control group, with P < 0.05. The study group had a smaller uterine volume (90.45 ± 5.19 cm3) than the control group, with P < 0.05. Conclusion Acupuncture is significantly effective in treating dysmenorrhea caused by adenomyosis, improving clinical symptoms, and alleviating pain, and is worthy of promotion.
Key words: Acupuncture; Adenomyosis dysmenorrhea; Symptom score; Pain level
参考文献 References
[1] 母苓,王淳,兰玛. 葫芦灸联合改良少腹逐瘀汤在子宫腺肌病中的临床应用 [J]. 中国计划生育和妇产科, 2024, 16 (10): 37-40.
[2] 吴天思,林晓华,秦玉璇,等. 针药结合治疗子宫腺肌病(气虚血瘀型)疗效及对患者卵巢功能、免疫功能影响观察 [J/OL]. 辽宁中医杂志, 1-9[2024-12-02].
[3] 吴天思,林晓华,秦玉璇,等. 参芪活血方联合针刺对气虚血瘀证子宫腺肌病患者的临床疗效 [J]. 中成药, 2024, 46 (10): 3533-3536.
[4] 王小曼,王景晓,刘昕朋. 聚焦超声消融手术治疗内在型子宫腺肌病的临床效果 [J]. 妇儿健康导刊, 2024, 3 (19): 25-28.
[5] 李彧,程雯,李森,等. 俞氏化瘀止血方联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的前瞻性、随机、双盲、安慰剂对照研究 [J]. 海军军医大学学报, 2024, 45 (09): 1069-1076.
[6] 管素芬,陈琰,王赛莉. 自拟补气消瘀方用于子宫腺肌病GnRHa治疗对患者中医证候、血清CA199、CA125的影响 [J]. 四川中医, 2024, 42 (09): 178-182.
[7] 王子卉,刘馥溧,黄艳辉. 黄艳辉从“杂合以治”治疗子宫腺肌病之经验探析 [J]. 亚太传统医药, 2024, 20 (09): 91-94.
[8] 文怡. 子宫肌瘤和子宫腺肌病聚焦超声消融手术术后中医辨证治疗 [J]. 中国实用妇科与产科杂志, 2024, 40 (09): 908-912.
[9] 侯学思,赵吉平,王宁,等. 针刺治疗子宫腺肌病继发性痛经:前瞻性病例系列研究 [J]. 中国针灸, 2020, 40 (08): 834-838.
[10] 黄辉霞,贾节,刘津. 基于超声剪切波弹性成像与红热外成像技术探讨浮针治疗子宫腺肌病痛经的研究 [J]. 中国当代医药, 2024, 31 (09): 69-74.
[11] 杨正乔,姚倩,高仁美,等. 针药联合治疗气滞血瘀型子宫腺肌病痛经的临床观察 [J]. 国医论坛, 2024, 39 (02): 41-43.